CONCENTRATIONS OF APOLIPOPROTEINS E, C2 AND C3 AND LIPID PROFILE IN PREECLAMPSIA

Objective: Preeclampsia is associated with an abnormal lipid profile and high apolipoprotein E (Apo E) levels. Apo E may favor lipid uptake by macrophages and is thought to increase triglycerides clearance. However, high Apo E levels may interfere with lipolysis by interacting with the lipoprotein lipase (LPL) activator, apolipoprotein C2 (Apo C2). LPL activity may also be impaired by high levels of the LPL inhibitor apolipoprotein C3 (Apo C3). Therefore, lipid profile depends on the balance between the opposing effects of Apo C2 and Apo C3 and on interference due to Apo E. We investigated the involvement of these three lipoproteins in lipid disorders associated with preeclampsia. Methods: Blood samples were taken from 25 normotensive and 24 preeclamptic pregnant women after a 12-hr fasting period. These samples were analyzed for standard lipid profile and Apo E, C2, C3 concentrations. Results: Concentrations of triglycerides, total cholesterol, LDL, HDL, and LDL cholesterol did not differ significantly between preeclamptic women and pregnant controls. Apo C2 concentration and Apo E/Apo C2 ratio did not differ between the two groups of women but Apo C3 and Apo E concentrations were higher in preeclamptic than in pregnant controls. The ratio of triglycerides to Apo E was similar in the two groups of women. In both groups, triglycerides levels were positively correlated with Apo E (p=0.0429), Apo C2 (p=0.0045) and Apo C3 (p=0.0004) concentrations, but not with Apo E/Apo C2 ratio (p=0.760). Conclusions: In preeclamptic women, the increase in Apo E concentration may not increase triglycerides clearance because LPL activity seems to be inhibited by high Apo C3 concentration.

[1]  E. Herrera Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus , 2000, European journal of clinical nutrition.

[2]  D. Ramji,et al.  Lipoprotein lipase, a key role in atherosclerosis? , 1999, FEBS letters.

[3]  F. Esposito,et al.  Lipoprotein metabolism during normal pregnancy. , 1999, American journal of obstetrics and gynecology.

[4]  R. Mahley,et al.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.

[5]  L. Havekes,et al.  Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[6]  I. Johnson,et al.  Relationship between myometrial resistance artery behavior and circulating lipid composition. , 1999, American journal of obstetrics and gynecology.

[7]  D. Hadden,et al.  Insulin sensitivity in pre‐eclampsia , 1998, British journal of obstetrics and gynaecology.

[8]  A. Chait,et al.  Mechanisms of enhanced macrophage apoE secretion by oxidized LDL. , 1997, Journal of lipid research.

[9]  K. Conrad,et al.  Placental Cytokines and the Pathogenesis of Preeclampsia , 1997, American journal of reproductive immunology.

[10]  C. Packard,et al.  Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre‐eclampsia , 1996, British journal of obstetrics and gynaecology.

[11]  A. Chait,et al.  ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy. , 1996, Journal of lipid research.

[12]  R. Evans,et al.  Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. , 1996, American journal of obstetrics and gynecology.

[13]  D. Gómez-Coronado,et al.  Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. , 1988, American journal of obstetrics and gynecology.

[14]  R. Frydman,et al.  Implication of apolipoprotein E and the L-arginine-nitric oxide system in preeclampsia. , 1999, Hypertension in pregnancy.

[15]  Y. Matsuzawa,et al.  Determination by the SRID Method of Normal Values of Serum Apolipoproteins (A-I, A-II, B, C-II, C-III, and E) in Normolipidemic Healthy Japanese Subjects , 1986 .